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Introduction
Cholesterol and other lipids play an important role in the 
genesis of atherosclerosis and cardiovascular diseases. 
Lipids are transported in the bloodstream by lipoproteins.
These lipoproteins are principally spherical and have a 
hydrophobic core consisting of triglycerides and cholesteryl 
esters. This core is covered by a phospholipid monolayer, in 
which free cholesterol and so called apolipoproteins are 
located. The most common and referenced method to 
classify lipoproteins is by density. High density lipoproteins 
(HDL) and low density lipoproteins (LDL) are of great 
interest in lipid research.
Results
Our model is able to reproduce measured lipid data of 
humans with normal lipoprotein values. Furthermore, 
certain lipoprotein-associated diseases like 
hypercholesterolemia may be simulated by modifying the 
associated parameters of the metabolism.
As particular lipoproteins are simulated, we are able to get 
information about the distribution and metabolic rates of 
lipoproteins in any definable density classes. 
We are also able to get insights in the metabolic fate of 
specific lipoproteins by tracing them in the simulation.
Methods
Here, we present a refined version of a previously 
described model of the human lipoprotein metabolism.1 
The model describes the behaviour of particular 
lipoproteins dependent on a set of reaction rates. Due to 
the large number of possible lipoprotein compositions, the 
computation is done by the stochastic Gillespie algorithm. 
The now presented model is based on a comprehensive 
dataset of lipoprotein measurements in healthy and 
pathologic patients (n=1764) and contains several changes 
and refinements to the prior approach. So, based on this 
dataset, we are able to improve the phospholipid and free 
cholesterol computation. 
Our model takes into account, that the different reaction 
rates of lipoproteins with very low density (VLDL) and LDL 
lipoproteins are not only caused by simple mass action 
kinetics, but are also regulated by the different 
compositions of apolipoproteins. The immense size 
varieties of the particles (range of radius: 5 – 40 nm) are 
also taken into account in the reaction rate determination.
The bigger dataset provides us with more qualitative 
standard values for healthy and pathologic lipid and 
lipoprotein profiles.
Due to the work of Qiu et al.² we are able to refine the 
CETP exchange reactions by modelling the described ping 
pong bi-bi shuttle transport of lipids.³
The model is implemented in c++ and simulates the 
dynamics of lipoproteins in a 10-16 litre plasma, starting in a 
lipoprotein free situation.
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Discussion
The model is capable to investigate associated diseases of 
lipid metabolism and to provide a powerful tool for possible 
therapeutic approaches. 
However, as human lipoprotein metabolism is highly 
complex and not fully understood, there is a vast amount of 
possible improvements. So several reactions and 
apolipoprotein interactions are missing in the current model.
As (due to the model complexity) the simulation is only 
realizable in a relative small volume, stochastic influences 
may play a undesirable big role. Furthermore there are 
huge differences in the speed of the various reactions and 
number of lipoproteins in important subpopulations. 
Taking these issues into account a refined version of the 
computation may be beneficial.
Clinical measured values of n=143 normolipidemic patients (red) versus calculated profiles with 
error bars (blue) in 11 established density (sub-)fractions V=VLDL,I=IDL, L1-L6 (LDL 
subfractions 1-6) and HDL subfractions H2b=HDL2b, H2a=HDL2a, H3=HDL3
Structure of a triglycerid-rich lipoprotein with 
apolipoprotein B-100
(Nelson and Cox, 2006) 
An important regulator of 
the lipid metabolism in the 
human blood plasma is the 
cholesteryl ester transfer 
protein (CETP), which 
mediates the exchange of 
lipids from one lipoprotein to 
another. 
However, lipoprotein 
analysis is elaborate and 
expensive. A model 
predicting the risk of 
cardiovascular disease 
depending on the lipid 
metabolism may be of great 
benefit. 